Skip to main content

Urethral Cancer clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • 64Cu-GRIP B in Patients With Advanced Genitourinary Malignancies

    open to eligible people ages 18 years and up

    This is a first-in-human phase I/II imaging study of 64Cu-GRIP B PET in patients with advanced genitourinary (GU) malignancies. The tracer is designed to detect extracellular granzyme B as it is secreted by activated immune cells in the tumor microenvironment, which may highlight tumors that will regress on treatment with immunomodulatory therapies. The study population is focused on genitourinary malignancies, including renal cell and urothelial cancer, two tumor types with high mutational burden and tumor infiltrating lymphocytes compared to other tumor types, and have a predictable response rate at the population level to immune checkpoint inhibitors.

    San Francisco, California

Our lead scientists for Urethral Cancer research studies include .

Last updated: